Bioengine Capital Inc.
- SEC CIK
- 0001770197
No open-market purchases or sales filed in the past year.
Current role at each company
- WINT Windtree Therapeutics Inc10% Owneras of Jan 10, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Bioengine Capital Inc. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 10, 2022 (view filing) | May 20, 2020 | 600 daysLate | Bioengine Capital Inc.10% Owner | PPurchase | +55.2K | $7.25 | +$400.0K | +4.7%1.24M after | |
| Jan 10, 2022 (view filing) | Dec 30, 2021 | 11 daysLate | Bioengine Capital Inc.10% Owner | SSale | −1.24M | $1.60 | −$1.98M | −100.0%0 after | |
| Jan 10, 2022 (view filing) | May 20, 2020 | 600 daysLate | Bioengine Capital Inc.10% Owner | PPurchase | +55.2K | $0.00 | $0 | –55.2K after | Derivative |